Enhancing the Antifungal Efficacy of Fluconazole with a Diterpene: Abietic Acid as a Promising Adjuvant to Combat Antifungal Resistance in <i>Candida</i> spp.

The increasing antifungal resistance rates against conventional drugs reveal the urgent need to search for new therapeutic alternatives. In this context, natural bioactive compounds have a critical role in antifungal drug development. Since evidence demonstrates that abietic acid, a diterpene found...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Gabriely de Lima Silva (Author), Luciene Ferreira de Lima (Author), Victor Juno Alencar Fonseca (Author), Lucas Yure Santos da Silva (Author), Ana Cecília Calixto Donelardy (Author), Ray Silva de Almeida (Author), Cícera Datiane de Morais Oliveira-Tintino (Author), Anita Oliveira Brito Pereira Bezerra Martins (Author), Jaime Ribeiro-Filho (Author), Maria Flaviana Bezerra Morais-Braga (Author), Saulo Relison Tintino (Author), Irwin Rose Alencar de Menezes (Author)
Format: Book
Published: MDPI AG, 2023-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c5d1517b34914823b88ee6f18f8faac3
042 |a dc 
100 1 0 |a Maria Gabriely de Lima Silva  |e author 
700 1 0 |a Luciene Ferreira de Lima  |e author 
700 1 0 |a Victor Juno Alencar Fonseca  |e author 
700 1 0 |a Lucas Yure Santos da Silva  |e author 
700 1 0 |a Ana Cecília Calixto Donelardy  |e author 
700 1 0 |a Ray Silva de Almeida  |e author 
700 1 0 |a Cícera Datiane de Morais Oliveira-Tintino  |e author 
700 1 0 |a Anita Oliveira Brito Pereira Bezerra Martins  |e author 
700 1 0 |a Jaime Ribeiro-Filho  |e author 
700 1 0 |a Maria Flaviana Bezerra Morais-Braga  |e author 
700 1 0 |a Saulo Relison Tintino  |e author 
700 1 0 |a Irwin Rose Alencar de Menezes  |e author 
245 0 0 |a Enhancing the Antifungal Efficacy of Fluconazole with a Diterpene: Abietic Acid as a Promising Adjuvant to Combat Antifungal Resistance in <i>Candida</i> spp. 
260 |b MDPI AG,   |c 2023-10-01T00:00:00Z. 
500 |a 10.3390/antibiotics12111565 
500 |a 2079-6382 
520 |a The increasing antifungal resistance rates against conventional drugs reveal the urgent need to search for new therapeutic alternatives. In this context, natural bioactive compounds have a critical role in antifungal drug development. Since evidence demonstrates that abietic acid, a diterpene found in <i>Pinus</i> species, has significant antimicrobial properties, this study aimed to evaluate the antifungal activity of abietic acid against <i>Candida</i> spp and its ability to potentiate the activity of fluconazole. Abietic acid was tested both individually and in combination with fluconazole against <i>Candida albicans</i> (CA INCQS 40006), <i>Candida krusei</i> (CK INCQS 40095), and <i>Candida tropicalis</i> (CT INCQS 40042). The microdilution method was used to determine the IC<sub>50</sub> and the cell viability curve. Minimum Fungicidal Concentration (MFC) was determined by subculture in a solid medium. The plasma membrane permeability was measured using a fluorescent SYTOX Green probe. While the IC<sub>50</sub> of the drugs alone ranged between 1065 and 3255 μg/mL, the IC<sub>50</sub> resulting from the combination of abietic acid and fluconazole ranged between 7563 and 160.1 μg/mL. Whether used in combination with fluconazole or isolated, abietic acid exhibited Minimum Fungicidal Concentration (MFC) values exceeding 1024 μg/mL against <i>Candida albicans</i>, <i>Candida krusei</i> and <i>Candida tropicalis</i>. However, it was observed that the antifungal effect of fluconazole was enhanced when used in combination with abietic acid against <i>Candida albicans</i> and <i>Candida tropicalis</i>. These findings suggest that while abietic acid alone has limited inherent antifungal activity, it can enhance the effectiveness of fluconazole, thereby reducing antifungal resistance. 
546 |a EN 
690 |a anti-<i>Candida</i> activity 
690 |a abietic acid 
690 |a fluconazole 
690 |a antifungal resistance 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 12, Iss 11, p 1565 (2023) 
787 0 |n https://www.mdpi.com/2079-6382/12/11/1565 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/c5d1517b34914823b88ee6f18f8faac3  |z Connect to this object online.